Enter Ebglyss (Search)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Ebglyss ™ (lebrikizumab-lbkz) injection
250 mg/2 mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What is the half-life of Ebglyss™ (lebrikizumab-lbkz)?
The lebrikizumab half-life is 24.5 days and clearance is 0.154 L/day. Lebrikizumab exhibits linear elimination that is independent of dose.
Lebrikizumab Half-Life
The lebrikizumab-lbkz half-life is 24.5 days and clearance is 0.154 L/day. Lebrikizumab-lbkz exhibits linear elimination that is independent of dose.1
Enclosed Prescribing Information
References
1Ebglyss [package insert]. Indianapolis, IN: Eli Lilly and Company; 2024.
Date of Last Review: November 17, 2023
Are you satisfied with this content?